WWM
GILD icon

Western Wealth Management’s Gilead Sciences GILD Stock Holding History

Western Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Sell
7,933
-16
-0.2% -$2.11K 0.03% 474
2026
Q1 		$1.11M Buy
7,949
+4,068
+105% +$570K 0.04% 414
2025
Q4 		$476K Buy
3,881
+12
+0.3% +$1.46K 0.02% 527
2025
Q3 		$429K Buy
3,869
+6
+0.2% +$682 0.02% 480
2025
Q2 		$428K Buy
3,863
+23
+0.6% +$2.45K 0.03% 456
2025
Q1 		$430K Sell
3,840
-4,681
-55% -$483K 0.03% 434
2024
Q4 		$787K Buy
8,521
+49
+0.6% +$4.41K 0.04% 354
2024
Q3 		$710K Buy
8,472
+4,762
+128% +$363K 0.04% 366
2024
Q2 		$255K Sell
3,710
-1,630
-31% -$109K 0.02% 548
2024
Q1 		$391K Sell
5,340
-3,283
-38% -$252K 0.03% 428
2023
Q4 		$699K Buy
8,623
+576
+7% +$44.8K 0.05% 340
2023
Q3 		$603K Buy
8,047
+5,361
+200% +$412K 0.05% 343
2023
Q2 		$207K Buy
2,686
+7
+0.3% +$558 0.02% 605
2023
Q1 		$222K Buy
2,679
+7
+0.3% +$580 0.02% 585
2022
Q4 		$229K Sell
2,672
-6,271
-70% -$497K 0.02% 540
2022
Q3 		$554K Sell
8,943
-673
-7% -$42.4K 0.03% 447
2022
Q2 		$596K Buy
9,616
+1,039
+12% +$64.3K 0.03% 425
2022
Q1 		$510K Buy
8,577
+2,725
+47% +$174K 0.02% 526
2021
Q4 		$426K Buy
+5,852
New +$403K 0.04% 362
2021
Q2 		$323K Buy
+4,693
New +$313K 0.03% 474
2020
Q4 		– Sell
-3,692
Closed -$234K – 479
2020
Q3 		$234K Buy
3,692
+8
+0.2% +$555 0.04% 380
2020
Q2 		$283K Buy
3,684
+528
+17% +$40.5K 0.05% 328
2020
Q1 		$236K Buy
+3,156
New +$218K 0.05% 313
2019
Q1 		– Sell
-4,220
Closed -$267K – 385
2018
Q4 		$267K Buy
+4,220
New +$295K 0.07% 270

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Western Wealth Management's GILD Position: Q2 2026 in Review

Western Wealth Management reduced its Gilead Sciences (GILD) stake by 0.2% in Q2 2026, selling an estimated $2.11K and leaving 7,933 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #474.

Western Wealth Management first reported a position in GILD in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.11M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Western Wealth Management held 7,933 shares of Gilead Sciences worth $1M as of Q2 2026.
  • Western Wealth Management sold 16 Gilead Sciences shares in Q2 2026, an estimated $2.11K.
  • Gilead Sciences made up 0.03% of Western Wealth Management's portfolio in Q2 2026, its #474 holding.
  • Western Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 24 quarters since.
  • Western Wealth Management's Gilead Sciences position peaked at $1.11M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.